Autopsy report · NCT04360967

SURF, Neurodevelopment, Growth Study in SGA Infants

“Sponsor decision stopped in June 2017”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Société des Produits Nestlé (SPN)

Sponsor type

Industry

Conditions

Infant, Small for Gestational Age

Interventions

Standard Formula; Nutrient-enriched Formula

Participants

0

Trials that died the same way

• Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer
  “Sponsor chose not to continue” (81% match in meaning)
• A Post-Market Clinical Evaluation of the ReUnion Reverse Shoulder Arthroplasty (RSA) System
  “Sponsor decision to stop at 2 year follow-up” (80% match in meaning)
• Phase 2 RCT of Alvimopan vs. Placebo After CRS/HIPEC
  “stopped by sponsor” (79% match in meaning)
• Target Volume Mode Controlled Ventilator in Obesity Hypoventilation Syndrome
  “Stopped by the sponsor” (79% match in meaning)
• Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
  “Study has been stopped by sponsor decision.” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.